Reckitt (GB:RKT)
LSE:RKT
Want to see GB:RKT full AI Analyst Report?
RKT Stock Chart & Stats
5180.00 p
12.00 p(0.24%)
At close: 4:00 PM EST
5180.00 p
12.00 p(0.24%)
Day’s Range― - ―
52-Week Range3,664.00 p - 6,522.92 p
Previous CloseN/A
Volume39.10K
Average Volume (3M)1.55M
Market Cap
£29.30B
Enterprise Value35.70B
Total Cash (Recent Filing)£1.95B
Total Debt (Recent Filing)£8.43B
Price to Earnings (P/E)9.4
Beta0.89
Next Earnings
Jul 29, 2026EPS Estimate
1.5Next Dividend Ex-DateN/A
Dividend Yield3.44%
Share Statistics
EPS (TTM)4.16
Shares Outstanding635,048,800
10 Day Avg. Volume1,239,780
30 Day Avg. Volume1,554,548
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)5.26
Price to Sales (P/S)2.87
P/FCF Ratio23.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£6,193.00Price Target Upside19.56% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)3.33
Revenue Forecast (FY)£12.74B
Bulls Say, Bears Say
Bulls Say
Emerging Markets OutperformanceSustained double-digit EM growth signals structural demand and geographic diversification that drive higher volumes and better margins over time. Strong China and India performance gives durable top-line momentum, supports scale economies, and reduces reliance on slower developed markets for 2–6 month horizon and beyond.
Strong Brand Portfolio And InnovationA broad stable of globally recognized brands plus regular product innovation strengthens pricing power and retailer support. FDA‑level approvals and cross-category launches increase shelf presence and defend share versus private labels, underpinning recurring demand and margin resilience over the medium term.
Material Improvement In Profitability And LeverageA step‑up in margins and a much lower debt ratio materially improve financial flexibility and reduce risk of distress. Higher profitability funds reinvestment and shareholder returns, and a stronger balance sheet supports ongoing capex for supply‑chain automation and brand investment on a sustainable footing.
Bears Say
Weakening Cash Conversion DynamicsEarnings outpacing operating cash flow indicates working‑capital or timing volatility that can constrain free cash availability for buybacks, dividends or reinvestment. If cash conversion remains weaker, it raises execution risk for capital returns and the Fuel for Growth program over the coming months.
European Revenue And Share PressurePersistent weakness and higher promotional activity in Europe signal structural competitive and pricing pressure in a major market. Continued share erosion or margin hit in Europe would dampen group growth and impede margin recovery, presenting a multi‑quarter headwind to consistent earnings improvement.
Stranded Costs And Near‑term Leverage Rise From DivestmentOne‑off stranded costs and a planned temporary increase in leverage reduce near‑term financial flexibility and raise funding costs. That pressure could limit discretionary investment and increase execution risk for restructuring targets until deleveraging resumes post‑2026, affecting medium‑term margin visibility.
Reckitt News
RKT FAQ
What was Reckitt’s price range in the past 12 months?
Reckitt lowest share price was 3664.00 p and its highest was 6522.92 p in the past 12 months.
What is Reckitt’s market cap?
Reckitt’s market cap is £29.30B.
When is Reckitt’s upcoming earnings report date?
Reckitt’s upcoming earnings report date is Jul 29, 2026 which is in 38 days.
How were Reckitt’s earnings last quarter?
Reckitt released its earnings results on Mar 05, 2026. The company reported 1.844 p earnings per share for the quarter, missing the consensus estimate of 1.883 p by -0.039 p.
Is Reckitt overvalued?
According to Wall Street analysts Reckitt’s price is currently Undervalued.
Does Reckitt pay dividends?
Reckitt pays a Quarterly dividend of 127.8 p which represents an annual dividend yield of 3.44%. See more information on Reckitt dividends here
What is Reckitt’s EPS estimate?
Reckitt’s EPS estimate is 1.5.
How many shares outstanding does Reckitt have?
Reckitt has 635,048,800 shares outstanding.
What happened to Reckitt’s price movement after its last earnings report?
Reckitt reported an EPS of 1.844 p in its last earnings report, missing expectations of 1.883 p. Following the earnings report the stock price went down -5.785%.
Which hedge fund is a major shareholder of Reckitt?
Currently, no hedge funds are holding shares in GB:RKT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Reckitt Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
£6,193.00 (19.56% Upside)
£6,193.00 (19.56% Upside)
Blogger Sentiment
Bullish
GB:RKT Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth £2.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.01%
12-Months-Change
Fundamentals
Return on Equity
38.45%
Trailing 12-Months
Asset Growth
-0.91%
Trailing 12-Months
Company Description
Reckitt
Reckitt Benckiser Group plc is a global enterprise engaged in the production and distribution of consumer goods spanning the health, hygiene, and nutrition sectors. Its commercial reach extends throughout the United Kingdom, the United States, China, India, and numerous other international markets. The company's diverse product portfolio encompasses a wide array of personal health and wellness items. This includes acne treatments (e.g., Clearasil), sexual health products (such as Durex), and digestive aids (like Gaviscon for heartburn and indigestion). It also provides a variety of adult and children's remedies for coughs, colds, and sinus issues (including Mucinex and Delsym), alongside pain relievers (Nurofen, Biofreeze), sore throat medications (Strepsils, Cepacol), and hair removal products (Veet). Reckitt Benckiser also holds a significant presence in specialized nutrition and dietary supplements. Offerings in this segment include adult nutrition products (Mead Johnson), infant and toddler formulas, including iron-fortified hypoallergenic options (Enfamil, Nutramigen), joint health supplements (Move Free), various vitamins, minerals, and general wellness supplements (Airborne), brain health support (Neuriva), Omega fatty acid products (MegaRed), and probiotics (Digestive Advantage, Bodi-Ome). Personal lubricants (K-Y) are also part of this extensive health and wellness range. Within the home care and hygiene segment, the company markets air fresheners (Air Wick), water softening agents (Calgon), and a comprehensive suite of cleaning products for dishes (Finish), toilets (Harpic), and general home surfaces (Cillit Bang, Easy-Off). This is complemented by powerful disinfectants and first aid solutions (Dettol, Lysol), pest control solutions (Mortein), stain removers (Vanish), fabric care items including plant-based options (Woolite, Botanical Origin), and specialized septic tank treatment products (RID-X). Established in 1819, the company maintains its corporate headquarters in Slough, United Kingdom.
RKT Stock 12 Month Forecast
Average Price Target
6,193.00 p
▲(19.56% Upside)
Technical Analysis
Associated British Foods
―
British American Tobacco
―
Coca Cola HBC
―
Imperial Brands
―
Unilever
―
Options Prices
Currently, No data available
---